Arcturus Therapeutics Holdings Inc. (ARCT)
USD 14.82
(-5.79%)
USD 14.82
(-5.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 157.74 Million | 205.75 Million | 12.35 Million | 9.53 Million | 20.78 Million | 15.75 Million |
| Cost of Revenue | 2.95 Million | 143.05 Million | 171.86 Million | 55.94 Million | 32.43 Million | 16.98 Million |
| Gross Profit | 154.79 Million | 62.7 Million | -159.5 Million | -46.4 Million | -11.65 Million | -1.22 Million |
| Operating Expenses | 245 Million | 193.57 Million | 215.21 Million | 81.06 Million | 46.3 Million | 37.56 Million |
| Selling, General and Administrative Expenses | 52.87 Million | 46.07 Million | 41.45 Million | 23.21 Million | 12.66 Million | 20.58 Million |
| Research and Development Expenses | 192.13 Million | 147.75 Million | 173.76 Million | 57.84 Million | 33.64 Million | 16.98 Million |
| Other Expenses | - | -244 Thousand | - | - | - | - |
| Cost and Expenses | 235.95 Million | 193.57 Million | 215.21 Million | 81.06 Million | 46.3 Million | 37.56 Million |
| Operating Income | -78.2 Million | 12.17 Million | -202.85 Million | -71.52 Million | -25.51 Million | -21.81 Million |
| Interest Expense | 767 Thousand | 420 Thousand | 2.67 Million | 361 Thousand | 446 Thousand | 186 Thousand |
| Income Tax Expense | 1.83 Million | 1.29 Million | 3.18 Million | -784 Thousand | -270 Thousand | 212 Thousand |
| Earnings before Tax | -27.89 Million | 10.64 Million | -203.67 Million | -72.14 Million | -25.99 Million | -21.78 Million |
| Net Income | -29.72 Million | 9.34 Million | -206.86 Million | -71.36 Million | -25.72 Million | -21.78 Million |
| Earnings Per Share Basic | -1.12 | 0.35 | -7.86 | -3.51 | -2.13 | -2.16 |
| Earnings Per Share Diluted | -1.12 | 0.35 | -7.86 | -3.51 | -2.13 | -2.16 |
| Weighted Average Shares Outstanding | 26.62 Million | 26.44 Million | 26.31 Million | 20.3 Million | 12.06 Million | 10.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.62 Million | 27.09 Million | 26.31 Million | 20.3 Million | 12.06 Million | 10.06 Million |
| Gross Margin | 0.98 | 0.30 | -12.91 | -4.86 | -0.56 | -0.08 |
| EBIT Margin | -0.15 | 0.06 | -16.21 | -7.53 | -1.23 | -1.33 |
| Profit Margin | -0.19 | 0.05 | -16.74 | -7.48 | -1.24 | -1.38 |
| EBITDA | -24.16 Million | 13.7 Million | -201.65 Million | -70.64 Million | -24.42 Million | -20.71 Million |
| Earnings Before Tax Margin | -0.50 | 0.06 | -16.41 | -7.50 | -1.23 | -1.38 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 45.97 Million | 32.59 Million | 157.74 Million | 28.21 Million | 43.37 Million | 9.56 Million |
| Cost of Revenue | 900 Thousand | -5.41 Million | 2.95 Million | 815 Thousand | 800 Thousand | 52.66 Million |
| Gross Profit | 45.07 Million | 38.01 Million | 154.79 Million | 27.39 Million | 42.57 Million | -43.1 Million |
| Operating Expenses | 47.75 Million | 63.01 Million | 158.94 Million | 38.5 Million | 62.69 Million | 64.93 Million |
| Selling, General and Administrative Expenses | 11.41 Million | 14.85 Million | - | 11.69 Million | 13.37 Million | 13.22 Million |
| Research and Development Expenses | 36.34 Million | 53.57 Million | - | 26.81 Million | 51.07 Million | 52.66 Million |
| Other Expenses | -3.88 Million | - | - | 3.27 Million | - | - |
| Cost and Expenses | 48.65 Million | 63.01 Million | 161.9 Million | 39.32 Million | 62.69 Million | 64.93 Million |
| Operating Income | -2.68 Million | -30.41 Million | -4.15 Million | -11.11 Million | -19.31 Million | -55.37 Million |
| Interest Expense | - | - | 767 Thousand | 4000.00 | 20 Thousand | - |
| Income Tax Expense | -150 Thousand | 368 Thousand | 1.83 Million | 262 Thousand | 893 Thousand | 577 Thousand |
| Earnings before Tax | -17.36 Million | -26.44 Million | -27.89 Million | -8.31 Million | -15.32 Million | -51.97 Million |
| Net Income | -17.21 Million | -26.81 Million | -29.72 Million | -8.57 Million | -16.22 Million | -52.55 Million |
| Earnings Per Share Basic | -0.64 | -1.00 | - | -0.32 | -0.61 | -1.98 |
| Earnings Per Share Diluted | -0.64 | -1.00 | - | -0.32 | -0.61 | -1.98 |
| Weighted Average Shares Outstanding | 26.96 Million | 26.87 Million | 26.62 Million | 26.62 Million | 26.57 Million | 26.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.96 Million | 26.87 Million | 26.62 Million | 26.62 Million | 26.57 Million | 26.56 Million |
| Gross Margin | 0.98 | 1.17 | 0.98 | 0.97 | 0.98 | -4.51 |
| EBIT Margin | -0.04 | -0.78 | - | -0.36 | -0.45 | -5.37 |
| Profit Margin | -0.37 | -0.82 | -0.19 | -0.30 | -0.37 | -5.49 |
| EBITDA | -1.78 Million | -25.49 Million | - | -10.29 Million | -19.31 Million | -51.38 Million |
| Earnings Before Tax Margin | -0.06 | -0.93 | -0.03 | -0.39 | -0.45 | -5.79 |
IOFNF
6817
7361
CLPI
ABL
HYSG